Bloomage Biotechnology (China) Performance
| 688363 Stock | 57.50 3.32 5.46% |
On a scale of 0 to 100, Bloomage Biotechnology holds a performance score of 6. The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Bloomage Biotechnology are expected to decrease at a much lower rate. During the bear market, Bloomage Biotechnology is likely to outperform the market. Please check Bloomage Biotechnology's total risk alpha, maximum drawdown, and the relationship between the jensen alpha and treynor ratio , to make a quick decision on whether Bloomage Biotechnology's price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bloomage Biotechnology Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bloomage Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Payout Ratio 0.4176 | Ex Dividend Date 2024-08-08 |
1 | Why Bloomage BioTechnologys Shaky Earnings Are Just The Beginning Of Its Problems - Simply Wall St | 11/06/2024 |
| Begin Period Cash Flow | 1.2 B |
Bloomage |
Bloomage Biotechnology Relative Risk vs. Return Landscape
If you would invest 4,907 in Bloomage Biotechnology Corp on August 25, 2024 and sell it today you would earn a total of 843.00 from holding Bloomage Biotechnology Corp or generate 17.18% return on investment over 90 days. Bloomage Biotechnology Corp is generating 0.3816% of daily returns and assumes 4.8306% volatility on return distribution over the 90 days horizon. Simply put, 43% of stocks are less volatile than Bloomage, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bloomage Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bloomage Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bloomage Biotechnology Corp, and traders can use it to determine the average amount a Bloomage Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.079
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688363 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.83 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Bloomage Biotechnology is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bloomage Biotechnology by adding it to a well-diversified portfolio.
Bloomage Biotechnology Fundamentals Growth
Bloomage Stock prices reflect investors' perceptions of the future prospects and financial health of Bloomage Biotechnology, and Bloomage Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bloomage Stock performance.
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 27.46 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 4.83 X | ||||
| Revenue | 6.08 B | ||||
| Gross Profit | 6.36 B | ||||
| EBITDA | 664.83 M | ||||
| Net Income | 592.56 M | ||||
| Total Debt | 153.13 M | ||||
| Book Value Per Share | 14.67 X | ||||
| Cash Flow From Operations | 699.65 M | ||||
| Earnings Per Share | 0.91 X | ||||
| Total Asset | 8.47 B | ||||
| Retained Earnings | 2.45 B | ||||
About Bloomage Biotechnology Performance
By analyzing Bloomage Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Bloomage Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bloomage Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bloomage Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bloomage Biotechnology is entity of China. It is traded as Stock on SHG exchange.Things to note about Bloomage Biotechnology performance evaluation
Checking the ongoing alerts about Bloomage Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bloomage Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bloomage Biotechnology had very high historical volatility over the last 90 days | |
| About 61.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Why Bloomage BioTechnologys Shaky Earnings Are Just The Beginning Of Its Problems - Simply Wall St |
- Analyzing Bloomage Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bloomage Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Bloomage Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bloomage Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bloomage Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bloomage Biotechnology's stock. These opinions can provide insight into Bloomage Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bloomage Stock analysis
When running Bloomage Biotechnology's price analysis, check to measure Bloomage Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomage Biotechnology is operating at the current time. Most of Bloomage Biotechnology's value examination focuses on studying past and present price action to predict the probability of Bloomage Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomage Biotechnology's price. Additionally, you may evaluate how the addition of Bloomage Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |